About the Project

This product was conceived to deliver new content & analytic capabilities for large/mid-sized hospitals and diagnostic laboratories who provide complex genetic patient data interpretation services to physicians and researchers, allowing Thomson Reuters Life Sciences division to drive revenue from a high growth market.

The tool gives molecular pathologists access to accurate and comprehensive content on gene variants via a simple user interface to interpret patient genetic tests, allowing them to deliver the best diagnosis and treatment options to their physician customers.